Please assess the completion status of the following clinical trial:

Trial Title: Bone Loss in Women With Anorexia Nervosa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Anorexia Nervosa,~* Over 18,~* Female,~* Decreased bone density~Exclusion Criteria:~* Medications to increase bone density

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 2 (Type: ACTIVE_COMPARATOR): Placebo Actonel (risedronate) and active testosterone patch
- 3 (Type: ACTIVE_COMPARATOR): Active Actonel (risedronate) and active testosterone patch
- 4 (Type: ACTIVE_COMPARATOR): Active Actonel (risedronate) and placebo testosterone
- 1 (Type: PLACEBO_COMPARATOR): Placebo testosterone patch and placebo Actonel (risedronate)

Based on this trial design, predict the completion outcome and termination type (if applicable).